anileridine
(LKYQLAWMNBFNJT-UHFFFAOYSA-N)
Structure
- SMILES
- CCOC(=O)C1(CCN(CC1)CCc1ccc(cc1)N)c1ccccc1
- Type(s)
- Approved; Illicit
- ATC code(s)
- N01AH05
- Molecular Formula:
- C22H28N2O2
- Molecular Weight:
- 352.470
- Log P:
- 3.9273
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 1
- TPSA:
- 55.56
- CAS Number(s):
- 144-14-9
Synonym(s)
1.
anileridine
2.
anileridine dihydrochloride
3.
anileridine hydrochloride
4.
anileridine monohydrochloride
5.
anileridine phosphate
6.
anileridine phosphate (1:1)
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Acute kidney injury | Canada Vigilance: 1 | Canada Vigilance | |
| 2 | Agitation | Canada Vigilance: 1 | Canada Vigilance | |
| 3 | Anaphylactoid Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 4 | Angioedema | Canada Vigilance: 1 | Canada Vigilance | |
| 5 | Asthenia | Canada Vigilance: 2 | Canada Vigilance | |
| 6 | Cardiac Arrest | Canada Vigilance: 2 | Canada Vigilance | |
| 7 | Cyanosis | Canada Vigilance: 2 | Canada Vigilance | |
| 8 | Delirium | 7541439 | CTD | |
| 9 | Dizziness | Canada Vigilance: 5 | Canada Vigilance | |
| 10 | Erythema Multiforme | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Flushing | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Hepatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Hypotension | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Injection Site Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Musculoskeletal stiffness | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Nausea | Canada Vigilance: 6 | Canada Vigilance | |
| 18 | Pain, Postoperative | 3755241 | CTD | |
| 19 | Pallor | Canada Vigilance: 2 | Canada Vigilance | |
| 20 | Pruritus | Canada Vigilance: 11 | Canada Vigilance | |
| 21 | Rash erythematous | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Respiratory Depression | Canada Vigilance: 4 | Canada Vigilance | |
| 23 | Shock | Canada Vigilance: 2 | Canada Vigilance | |
| 24 | Somnolence | Canada Vigilance: 4 | Canada Vigilance | |
| 25 | Stupor | Canada Vigilance: 2 | Canada Vigilance | |
| 26 | Tachycardia | Canada Vigilance: 3 | Canada Vigilance | |
| 27 | Visual Impairment | Canada Vigilance: 2 | Canada Vigilance | |
| 28 | Vomiting | Canada Vigilance: 6 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.